Markus Diefenhardt

8PUBLICATIONS
20CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2026
Trends in radiation oncology between 2015 and 2022: report from a German university radio-oncology department.

|Oct 25, 2025
Quality of life following total neoadjuvant therapy for rectal cancer.

Georg W Wurschi, Markus Diefenhardt, Justus Kaufmann

|Nov 09, 2024
Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?

Markus Diefenhardt, Daniel Martin, Maximilian Fleischmann

|Nov 26, 2022
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy.

Maximilian Fleischmann, Ranadip Mandal, Izabela Kostova

|Sep 23, 2022
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.

Markus Diefenhardt, Daniel Martin, Ethan B Ludmir

|Aug 12, 2022
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited.

Markus Diefenhardt, Anke Schlenska-Lange, Thomas Kuhnt

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Martin

1 joint publications

D Imhoff

1 joint publications

Guido Hildebrandt

1 joint publications

Ethan B Ludmir